Basappa, N. S. (2016) “Treatment options in advanced renal cell carcinoma after first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitors”, Canadian Urological Association Journal, 10(11-12), pp. S242–4. doi: 10.5489/cuaj.4292.